Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrienne D Cox

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|May 4, 2007
Geranylgeranyltransferase I as a target for anti-cancer drugsMark R Philips, Adrienne D Cox
Cancer Cell|June 16, 2012
Silencing the killers: paracrine immune suppression in pancreatic cancerAdrienne D Cox, Kenneth P Olive
Cancer Biology & Therapy|March 19, 2003
Ras family signaling: therapeutic targetingAdrienne D Cox, Channing J Der
Science (New York, N.Y.)|October 7, 2021
Filling in the GAPs in understanding RASAdrienne D Cox, Channing J Der
Oncogene|December 10, 2003
The dark side of Ras: regulation of apoptosisAdrienne D Cox, Channing J Der
Genes & Development|December 5, 2024
"Undruggable KRAS": druggable after allAdrienne D Cox, Channing J Der
Oncotarget|March 27, 2013
Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosisBatya Barkan, Adrienne D Cox, Yoel Kloog
Recent Patents on Anti-Cancer Drug Discovery|February 22, 2008
Inhibitors of chronically active ras: potential for treatment of human malignanciesRoy Blum, Adrienne D Cox, Yoel Kloog
Seminars in Cell & Developmental Biology|July 17, 2016
The role of wild type RAS isoforms in cancerBingying Zhou, Channing J Der, Adrienne D Cox
Methods in Molecular Biology (Clifton, N.J.)|January 29, 2014
Effector recruitment method to study spatially regulated activation of Ras and Rho GTPasesLauren P Huff, Molly J DeCristo, Adrienne D Cox
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|May 4, 2007
Geranylgeranyltransferase I as a target for anti-cancer drugsMark R Philips, Adrienne D Cox
Cancer Cell|June 16, 2012
Silencing the killers: paracrine immune suppression in pancreatic cancerAdrienne D Cox, Kenneth P Olive
Cancer Biology & Therapy|March 19, 2003
Ras family signaling: therapeutic targetingAdrienne D Cox, Channing J Der
Science (New York, N.Y.)|October 7, 2021
Filling in the GAPs in understanding RASAdrienne D Cox, Channing J Der
Oncogene|December 10, 2003
The dark side of Ras: regulation of apoptosisAdrienne D Cox, Channing J Der
Genes & Development|December 5, 2024
"Undruggable KRAS": druggable after allAdrienne D Cox, Channing J Der
Oncotarget|March 27, 2013
Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosisBatya Barkan, Adrienne D Cox, Yoel Kloog
Recent Patents on Anti-Cancer Drug Discovery|February 22, 2008
Inhibitors of chronically active ras: potential for treatment of human malignanciesRoy Blum, Adrienne D Cox, Yoel Kloog
Seminars in Cell & Developmental Biology|July 17, 2016
The role of wild type RAS isoforms in cancerBingying Zhou, Channing J Der, Adrienne D Cox
Methods in Molecular Biology (Clifton, N.J.)|January 29, 2014
Effector recruitment method to study spatially regulated activation of Ras and Rho GTPasesLauren P Huff, Molly J DeCristo, Adrienne D Cox
Pageof 11